Quanta Pharma BPC-157 5mg is a synthetic pentadecapeptide derived from human gastric juice. Researched extensively for tissue repair, gut healing, and recovery support. This stable peptide demonstrates remarkable effects on tendons, ligaments, muscles, and the gastrointestinal system. Lab verified 99.76% purity with 5.21mg actual content.
Independently Lab Verified
One new finished product test plus an independent blind screen
Quanta Pharma BPC-157 5mg is a pharmaceutical-grade synthetic pentadecapeptide derived from human gastric juice proteins. This lyophilised vial from Quanta Pharma offers researchers a high-purity compound for advanced studies in tissue regeneration, gut health, and musculoskeletal recovery. Independently lab-verified across two laboratories, most recently by Analiza Białek at 99% purity and 4.85mg content. Available for UK delivery with fast dispatch.
Quanta Pharma BPC-157 Specifications
BPC-157 5mg by Quanta Pharma
Quanta Pharma BPC-157 Research Benefits
- Tissue regeneration – Researched extensively for accelerating healing in tendons, ligaments, and muscle tissue
- Gut health support – Demonstrates protective effects on the gastrointestinal lining and inflammatory bowel conditions
- Joint recovery – Investigated for promoting cartilage and bone healing in musculoskeletal research
- Neuroprotective properties – Shows potential in studies examining nerve damage repair and brain injury recovery
- Anti-inflammatory action – Modulates inflammatory pathways without immunosuppressive side effects
How Quanta Pharma BPC-157 Works
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids. It is derived from a protective protein found naturally in human gastric juice, which contributes to gut mucosal integrity and tissue repair. Quanta Pharma produces this peptide to exacting pharmaceutical standards.
Research indicates BPC-157 works through multiple mechanisms including upregulation of growth hormone receptors, promotion of angiogenesis (new blood vessel formation), and modulation of the nitric oxide system. These pathways contribute to the remarkable tissue-healing properties observed in preclinical studies using Quanta Pharma peptides.
Quanta Pharma BPC-157 vs TB-500
While both BPC-157 and TB-500 from Quanta Pharma are researched for tissue repair, they work through different mechanisms. BPC-157 primarily affects the GI tract and localised tissue healing, whilst TB-500 (Thymosin Beta-4) promotes systemic tissue repair and cell migration. Many researchers combine both Quanta Pharma peptides in protocols for comprehensive recovery studies.
Why Choose Quanta Pharma BPC-157?
Quanta Pharma is renowned for producing pharmaceutical-grade peptides with exceptional purity and accurate dosing. Every batch of Quanta Pharma BPC-157 undergoes rigorous quality control and independent third-party testing through Janoshik laboratories. This commitment to quality ensures researchers receive consistent, reliable compounds for their studies.
⚠️ FOR LABORATORY RESEARCH USE ONLY
NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE
Safety Classification:
– For use by qualified research personnel only
– Keep detailed records of usage and storage as per UK research regulations
Legal Notice: This product is exclusively intended for in vitro laboratory research conducted in controlled environments by qualified research staff. It is not for pharmaceutical, domestic, or any other applications. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations concerning research chemicals.
